The next phase of JP2060 under Phase 4 will see a Health Knowledge Management (HKM) solution put in place for the ADF.
JP2060 Phase 4 seeks to acquire and sustain a commercial, information technology (IT), enterprise knowledge solution that captures health data, and collates and manages the information across the ADF health care continuum within the deployed and non-deployed, garrison environment.
The solution will be required to provide greater healthcare business functionality, utilise an efficient health informatics process and enable efficient and safe, evidenced based, patient-centric care.
The HKM solution will include a replacement primary care practice management system, a critical care patient management system and a new Defence eHealth Record for ADF members. It will be required to interface with Defence ICT platforms, allied coalition partners, Australian healthcare providers and nominated Government agencies such as Health.
The delivery timeframe is scheduled for 2020 for the first tranche of the system. The plan is to first roll out a new foundational record and primary care system to the 50-odd garrison sites in Australia and two overseas sites by December 2022, replacing the existing EMIS-based system implemented by DXC Technology, followed by an extended capability with analytics for deployed field hospitals by June 2025.
According to the last industry update on July 4, the HKM solution will be a predominately commercial-off-the shelf solution that meets Australian Clinical Practice Guidelines and is operating in the Australian market.
“The industry briefing held on 4 July 2019 for Joint Project 2060 Phase 4 – Health Knowledge Management was to approved suppliers on the Defence ICT Provider Arrangement (ICTPA) panel,” a Defence spokesperson said in answer to questions about the event.
“As this is a closed panel and a restricted tender, the industry briefing slide pack presented cannot be released. Defence does not divulge specific budgets for major Integrated Investment Program (IIP) projects.”
Industry estimates put the program value at between $350-$500 million.
An AusTender search also reveals that KPMG has been paid over $2.8 million between August 2016 and now for consulting services into the program.
There are a few players in the market that are eying this program, with teams led by Leidos and Deloitte amongst them. ADM understands that Accenture were noticeable by their absence on the industry day but are still in the mix, along with other companies such as Babcock and Fujitsu.
Deloitte has teamed with Allscripts Australia and a number of specialist Australian and international companies to develop a comprehensive, low-risk health knowledge management solution for Defence.
The Deloitte team comprises key leaders with an intimate knowledge of the ADF’s operating environment and clinical governance framework while Allscripts has first-hand experience in designing and implementing health information management solutions in a military context, according to Deloitte.
While not a traditional ICT prime, Deloitte is looking to provide a ‘clean slate’ approach to the program.
“Leidos has teamed with local and international companies with extensive expertise in Health and Defence environments, including leading companies Cerner and Henry Schein,” according to a statement from Leidos.
“This particular teaming arrangement has demonstrated significant success in the delivery of the US Department of Defense’s health modernisation program MHS GENESIS. Leidos intends to transfer these capabilities and lessons learned to Australia and, in collaboration with highly experienced Australian teammates, will provide a compelling solution for the ADF.”
ADM understands that further members of the Leidos team will be announced in due course.
ADM Comment: JP 2060 is one of those programs that ADM has been covering for many years now. For a program that has AusTender contracts listed for capability definition in 2007, scheduling support in 2008 and a range of other professional services for over a decade, progress for health capability has been slow even by Defence standards.
While the deployable side of the equation under Phase 3 has seen the Saab led team selected as the preferred tenderer, ADM understands that contract negotiations on that phase are not due to start until November this year.
Phase 4 is more of an ICT based system that will see numerous systems consolidated into a single point of truth as it were.
The ADF has been in a position where they have been able to leverage coalition health assets on many deployments, but this might not always be the case. The linkages between health services in Australia and on deployment have been inconsistent for some time. ADM hopes that the various phases of JP 2060 can resolve this issue sooner rather than later.